{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T01:06:59Z","timestamp":1790644019054,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,14]],"date-time":"2021-07-14T00:00:00Z","timestamp":1626220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","award":["CU-GRS-62-02-30-01"],"award-info":[{"award-number":["CU-GRS-62-02-30-01"]}],"id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.livres.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T06:02:35Z","timestamp":1626415355000},"page":"30-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical outcome of Yttrium-90 selective internal radiation therapy (Y-90 SIRT) in unresectable hepatocellular carcinoma: Experience from a tertiary care center"],"prefix":"10.1016","volume":"6","author":[{"given":"Jukkaphop","family":"Chaikajornwat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasu","family":"Tanasoontrarat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chonlada","family":"Phathong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nutcha","family":"Pinjaroen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7191-3881","authenticated-orcid":false,"given":"Roongruedee","family":"Chaiteerakij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2021.07.001_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.livres.2021.07.001_bib2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2021.07.001_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"Electronic address: easloffice@easloffice.eu; European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2021.07.001_bib4","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep4.1236","article-title":"Advanced hepatocellular carcinoma tumor stage at diagnosis in the 1945-1965 birth cohort reflects poor use of hepatocellular carcinoma screening","volume":"2","author":"Robinson","year":"2018","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.livres.2021.07.001_bib5","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s12325-016-0324-7","article-title":"Transarterial radioembolization with Yttrium-90 for the treatment of hepatocellular carcinoma","volume":"33","author":"Kallini","year":"2016","journal-title":"Adv Ther"},{"key":"10.1016\/j.livres.2021.07.001_bib6","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00000658-196508000-00018","article-title":"Treatment of inoperable primary pancreatic and liver cancer by the intra-arterial administration of radioactive isotopes (Y90 radiating microspheres)","volume":"162","author":"Ariel","year":"1965","journal-title":"Ann Surg"},{"key":"10.1016\/j.livres.2021.07.001_bib7","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1053\/j.gastro.2010.10.049","article-title":"Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma","volume":"140","author":"Salem","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2021.07.001_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/liv.12637","article-title":"In intermediate stage hepatocellular carcinoma: radioembolization with yttrium 90 or chemoembolization?","volume":"35","author":"El Fouly","year":"2015","journal-title":"Liver Int"},{"key":"10.1016\/j.livres.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/j.cgh.2013.04.028","article-title":"Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization","volume":"11","author":"Salem","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/hep.29086","article-title":"AASLD guidelines for the treatment of hepatocellular carcinoma","volume":"67","author":"Heimbach","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2021.07.001_bib12","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2021.07.001_bib13","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A\u00a0comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.livres.2021.07.001_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/hep.21980","article-title":"Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis","volume":"47","author":"Kulik","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2021.07.001_bib15","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S1470-2045(17)30683-6","article-title":"Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial","volume":"18","author":"Vilgrain","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.livres.2021.07.001_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0216935","article-title":"Yttrium-90 trans-arterial radioembolization in advanced-stage HCC: the impact of portal vein thrombosis on survival","volume":"14","author":"Somma","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.livres.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/BF01084369","article-title":"Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours","volume":"23","author":"Ho","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.livres.2021.07.001_bib18","article-title":"Clinical characteristics and prognosis of 2887 patients with hepatocellular carcinoma: a single center 14 years experience from China","volume":"9","author":"Wang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.livres.2021.07.001_bib19","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1002\/hep.23944","article-title":"Radioembolization with yttrium-90 glass microspheres in hepatocellular carcinoma: European experience on safety and long-term survival","volume":"52","author":"Hilgard","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2021.07.001_bib20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/hep.24451","article-title":"Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation","volume":"54","author":"Sangro","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2021.07.001_bib21","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/hep.26014","article-title":"Yttrium-90 radioembolization for intermediate-advanced hepatocellular carcinoma: a phase 2 study","volume":"57","author":"Mazzaferro","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2021.07.001_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2009.09.006","article-title":"Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes","volume":"138","author":"Salem","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2021.07.001_bib23","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jval.2016.09.2397","article-title":"Real-world data for the evaluation of transarterial radioembolization versus sorafenib in hepatocellular carcinoma: a cost-effectiveness analysis","volume":"20","author":"Rognoni","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/j.livres.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.livres.2021.07.001_bib25","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/hep.27057","article-title":"Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy","volume":"60","author":"Vouche","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2021.07.001_bib26","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jhep.2014.03.023","article-title":"Prospective randomized pilot study of Y90+\/-sorafenib as bridge to transplantation in hepatocellular carcinoma","volume":"61","author":"Kulik","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.livres.2021.07.001_bib27","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.transproceed.2014.11.004","article-title":"Radioembolization using yttrium-90 microspheres as bridging and downstaging treatment for unresectable hepatocellular carcinoma before liver transplantation: initial single-center experience","volume":"47","author":"Abdelfattah","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.livres.2021.07.001_bib28","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.2967\/jnumed.117.199752","article-title":"90Y radioembolization for locally advanced hepatocellular carcinoma with portal vein thrombosis: long-term outcomes in a 185-patient cohort","volume":"59","author":"Abouchaleh","year":"2018","journal-title":"J\u00a0Nucl Med"},{"key":"10.1016\/j.livres.2021.07.001_bib29","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.2147\/OTT.S92473","article-title":"Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma","volume":"8","author":"Lee","year":"2015","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.livres.2021.07.001_bib30","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s12032-017-1021-3","article-title":"Yttrium-90 radioembolization treatment for unresectable hepatocellular carcinoma: a single-centre prognostic factors analysis","volume":"34","author":"Floridi","year":"2017","journal-title":"Med Oncol"},{"key":"10.1016\/j.livres.2021.07.001_bib31","first-page":"469","article-title":"Radioembolization with Yttrium-90 microspheres for patients with unresectable hepatocellular carcinoma","volume":"6","author":"Bhangoo","year":"2015","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.livres.2021.07.001_bib32","doi-asserted-by":"crossref","first-page":"799","DOI":"10.21037\/jgo.2017.08.03","article-title":"Selective internal radiation therapy using yttrium-90 resin microspheres in patients with unresectable hepatocellular carcinoma: a retrospective study","volume":"8","author":"Mantry","year":"2017","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.livres.2021.07.001_bib33","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/hepr.12759","article-title":"Effect of yttrium-90 radioembolization on outcomes in Asian patients with early to advanced stage hepatocellular carcinoma","volume":"47","author":"Woo","year":"2017","journal-title":"Hepatol Res"},{"key":"10.1016\/j.livres.2021.07.001_bib34","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s12072-014-9533-9","article-title":"Survival and pattern of tumor progression with yttrium-90 microsphere radioembolization in predominantly hepatitis B Asian patients with hepatocellular carcinoma","volume":"8","author":"Khor","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.livres.2021.07.001_bib35","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.ejrad.2013.02.018","article-title":"Exploring intra- and inter-reader variability in uni-dimensional, bi-dimensional, and volumetric measurements of solid tumors on CT scans reconstructed at different slice intervals","volume":"82","author":"Zhao","year":"2013","journal-title":"Eur J Radiol"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568421000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568421000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:45:26Z","timestamp":1762872326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568421000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2542568421000441"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2021.07.001","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcome of Yttrium-90 selective internal radiation therapy (Y-90 SIRT) in unresectable hepatocellular carcinoma: Experience from a tertiary care center","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}